• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION IMPLANTABLE NEUROSTIMULATOR; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION IMPLANTABLE NEUROSTIMULATOR; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS Back to Search Results
Model Number NEU_INS_STIMULATOR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Intracranial Hemorrhage (1891)
Event Date 04/21/2022
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: product id: 3389 ,lot#: unknown, product type: lead.Other relevant device(s) are: product id: 3389, serial/lot #: unknown.Fan s, liu d, shi l, meng f, fang h, liu h, zhang h, yang a, zhang j, differential effects of subthalamic nucleus and globus pallidus internus deep brain stimulation on motor subtypes in parkinson¿s disease, world neurosurgery (2022), doi: https://doi.Org/10.1016/j.Wneu.2022.04.084.This value is the average age of the patients reported in the article as specific patients could not be identified.This value reflects the gender of the majority of the patients reported in the article as specific patients could not be identified.Date of event: please note that this date is based off of the date of publication of the article [or the date that the article was accepted for publication] as the event dates were not provided in the published literature.Event: it was not possible to ascertain specific device information from the article or to match the events reported with previously reported events.Correspondence has been sent to the author of the article inquiring about individual patient information and additional information regarding the reported events.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Fan s, liu d, shi l, meng f, fang h, liu h, zhang h, yang a, zhang j, differential effects of subthalamic nucleus and globus pallidus internus deep brain stimulation on motor subtypes in parkinson¿s disease, world neurosurgery (2022), doi: https://doi.Org/10.1016/j.Wneu.2022.04.084.Summary: objective: to investigate differences in motor symptom change outcomes following bilateral subthalamic nucleus (stn) and globus pallidus internus (gpi) deep brain stimulation (dbs) in well-defined motor subtypes of parkinson¿s disease (pd) to improve clinical decision making.Methods: we included 114 patients undergoing stn-dbs and 65 patients undergoing gpi-dbs.The patients were classified as akinetic-rigid type (art), tremor-dominant type (td), and mixed type (mt) based on the preoperative the movement disorder society unified parkinson¿s disease rating scale part-¿ (mds-updrs-iii) scores in the medication-off state.Outcome measures included the med-off mds-updrs-iii and its subscores changes at the last follow-up after surgery.Outcomes were compared among different motor subtypes and between stn-dbs and gpi-dbs.Results: at the last follow-up (14.92 ± 8.35 months), td patients had greater median overall motor improvement in med-off mds-updrs-iii scores compared with art patients (62.90% vs 46.67%, p <(><<)> 0.001), regardless of stimulation target.Art patients showed greater improvement after stn-dbs compared with gpi-dbs (54.44% vs 37.21%, p <(><<)> 0.001), with improvement in rigidity, akinesia, and posture and gait disorders accounting for this difference.Conclusions: our results suggest that the different pd motor subtypes show differential responses to stn-dbs and gpi-dbs, that td patients have greater improvement than art patients, and stn-dbs has a better effect in art patients than gpi-dbs.Besides, different motor symptoms among di fferent motor subtypes may respond differently to stn-dbs vs gpi-dbs.All above may reflect the heterogeneity of pd.Longer-term outcomes across different motor subtypes and stimulation targets should be further studied.Reported events: one patient had a small amount of intracranial hemorrhage after stn-dbs, and the hematoma gradually disappeared after conservative treatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE NEUROSTIMULATOR
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key14650765
MDR Text Key294864901
Report Number2182207-2022-01043
Device Sequence Number1
Product Code MHY
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P960009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/09/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEU_INS_STIMULATOR
Device Catalogue NumberNEU_INS_STIMULATOR
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/12/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age62 YR
Patient SexMale
-
-